OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis
Qi Wang, Hong Zhao, You Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1564-1572
Open Access | Times Cited: 56
Qi Wang, Hong Zhao, You Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1564-1572
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Gong Feng, Luca Valenti, Vincent Wai‐Sun Wong, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 46-56
Closed Access | Times Cited: 95
Gong Feng, Luca Valenti, Vincent Wai‐Sun Wong, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 1, pp. 46-56
Closed Access | Times Cited: 95
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
Hong You, Fu‐Sheng Wang, Taisheng Li, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 89
Hong You, Fu‐Sheng Wang, Taisheng Li, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 89
Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
Georg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1041-1052
Open Access | Times Cited: 55
Georg Semmler, Zhenwei Yang, Laurenz Fritz, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1041-1052
Open Access | Times Cited: 55
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis—A real-world case series
Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Hepatology (2024) Vol. 80, Iss. 3, pp. 664-673
Open Access | Times Cited: 11
Christopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Hepatology (2024) Vol. 80, Iss. 3, pp. 664-673
Open Access | Times Cited: 11
Acute and non‐acute decompensation of liver cirrhosis (47/130)
Martin S. Schulz, Paolo Angeli, Jonel Trebicka
Liver International (2024)
Open Access | Times Cited: 9
Martin S. Schulz, Paolo Angeli, Jonel Trebicka
Liver International (2024)
Open Access | Times Cited: 9
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis
Benedikt Hofer, Lukas Burghart, Emina Halilbasic, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 962-972
Open Access | Times Cited: 7
Benedikt Hofer, Lukas Burghart, Emina Halilbasic, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 962-972
Open Access | Times Cited: 7
Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery
Gong Feng, Yu Han, Wah Yang, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 6
Gong Feng, Yu Han, Wah Yang, et al.
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 6
Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
Madhumita Premkumar, Radha K. Dhiman, Ajay Duseja, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1429-1445
Closed Access | Times Cited: 6
Madhumita Premkumar, Radha K. Dhiman, Ajay Duseja, et al.
Gastroenterology (2024) Vol. 167, Iss. 7, pp. 1429-1445
Closed Access | Times Cited: 6
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa
Mark Sonderup, Patrick S. Kamath, Yaw Asante Awuku, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 170-184
Closed Access | Times Cited: 5
Mark Sonderup, Patrick S. Kamath, Yaw Asante Awuku, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 170-184
Closed Access | Times Cited: 5
A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma
Linhua Liu, Bing Wang, Yibo Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Linhua Liu, Bing Wang, Yibo Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Radiomic Analysis of Contrast‐Enhanced CT Predicts Recompensation in Hepatitis B‐Related Decompensated Cirrhosis
Qiaofeng Chen, Yuanping Fan, Kaini Wu, et al.
Portal hypertension & cirrhosis (2025)
Open Access
Qiaofeng Chen, Yuanping Fan, Kaini Wu, et al.
Portal hypertension & cirrhosis (2025)
Open Access
Recompensation of decompensated cirrhosis in hepatitis C patients after SVR: Prognostic implications
Yolanda Sánchez‐Torrijos, Paula Álvarez, José Miguel Rosales Zábal, et al.
Journal of Hepatology (2025)
Closed Access
Yolanda Sánchez‐Torrijos, Paula Álvarez, José Miguel Rosales Zábal, et al.
Journal of Hepatology (2025)
Closed Access
Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections
Zbigniew Wyżewski, Karolina P. Gregorczyk-Zboroch, Matylda Barbara Mielcarska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2385-2385
Open Access
Zbigniew Wyżewski, Karolina P. Gregorczyk-Zboroch, Matylda Barbara Mielcarska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2385-2385
Open Access
National Protect Liver Day 2025 in China: Integrating Traditional Chinese Medicine and Western Medicine to Reverse Liver Cirrhosis
Cuicui Shi, Jian-Gao Fan
Liver Research (2025)
Open Access
Cuicui Shi, Jian-Gao Fan
Liver Research (2025)
Open Access
Recompensation in Cirrhosis: Biomarkers and Strategies
Wagner Ramírez-Quesada, Edilmar Alvarado‐Tápias, Sarah Shalaby, et al.
Seminars in Liver Disease (2025)
Closed Access
Wagner Ramírez-Quesada, Edilmar Alvarado‐Tápias, Sarah Shalaby, et al.
Seminars in Liver Disease (2025)
Closed Access
Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
Vicki Wing‐Ki Hui, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100814-100814
Open Access | Times Cited: 11
Vicki Wing‐Ki Hui, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, et al.
JHEP Reports (2023) Vol. 5, Iss. 9, pp. 100814-100814
Open Access | Times Cited: 11
Compensated liver cirrhosis: Natural course and disease-modifying strategies
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash
World Journal of Methodology (2023) Vol. 13, Iss. 4, pp. 179-193
Open Access | Times Cited: 11
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash
World Journal of Methodology (2023) Vol. 13, Iss. 4, pp. 179-193
Open Access | Times Cited: 11
Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis
You Deng, Haiyan Kang, Huiling Xiang, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101091-101091
Open Access | Times Cited: 4
You Deng, Haiyan Kang, Huiling Xiang, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101091-101091
Open Access | Times Cited: 4
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)
Xiaoyuan Xu, Huiguo Ding, Wengang Li, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Xiaoyuan Xu, Huiguo Ding, Wengang Li, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver Aetiology
Yu Shi, Nicholas Chien, Ashley Fong, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Yu Shi, Nicholas Chien, Ashley Fong, et al.
Alimentary Pharmacology & Therapeutics (2025)
Closed Access
Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease
Marta Tonon, Roberta Gagliardi, Enrico Pompili, et al.
Journal of Hepatology (2025)
Closed Access
Marta Tonon, Roberta Gagliardi, Enrico Pompili, et al.
Journal of Hepatology (2025)
Closed Access
Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria
Long Gao, Man-Biao Li, Jinyu Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 38, pp. 5383-5394
Open Access | Times Cited: 9
Long Gao, Man-Biao Li, Jinyu Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 38, pp. 5383-5394
Open Access | Times Cited: 9
Comprehensive approach to controlling chronic hepatitis B in China
Shan Shan, Xinyan Zhao, Jidong Jia
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 135-143
Open Access | Times Cited: 3
Shan Shan, Xinyan Zhao, Jidong Jia
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 135-143
Open Access | Times Cited: 3
Liver Cirrhosis and Portal Hypertension
Dinesh Jothimani, Mohamed Rela, Patrick S. Kamath
Medical Clinics of North America (2023) Vol. 107, Iss. 3, pp. 491-504
Closed Access | Times Cited: 8
Dinesh Jothimani, Mohamed Rela, Patrick S. Kamath
Medical Clinics of North America (2023) Vol. 107, Iss. 3, pp. 491-504
Closed Access | Times Cited: 8
